Assyro AI

FDA Orange Book · active-ingredient family

Iron dextran

Iron dextran is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:INFED · NDA 017441

4

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
INFEDRLDALLERGANNDA 017441BPApproved Prior to Jan 1, 1982
DEXFERRUMAM REGENTNDA 040024Feb 23, 1996
IRON DEXTRANSANOFI AVENTIS USNDA 010787Approved Prior to Jan 1, 1982
PROFERDEXNEW RIVERNDA 017807Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Iron dextran — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.